Valhi, Inc. engages in the chemicals, components, and real estate development and management businesses in Asia Pacific, Europe, North America, and internationally.
| Revenue (TTM) | $2.10B |
| Gross Profit (TTM) | $279.80M |
| EBITDA | $49.90M |
| Operating Margin | 5.39% |
| Return on Equity | -5.02% |
| Return on Assets | -0.42% |
| Revenue/Share (TTM) | $73.63 |
| Book Value | $35.90 |
| Price-to-Book | 0.40 |
| Price-to-Sales (TTM) | 0.18 |
| EV/Revenue | 0.408 |
| EV/EBITDA | 12.83 |
| Quarterly Earnings Growth (YoY) | -88.10% |
| Quarterly Revenue Growth (YoY) | 4.00% |
| Shares Outstanding | $28.30M |
| Float | $2.38M |
| % Insiders | 91.60% |
| % Institutions | 4.08% |
Volatility is currently expanding
Valhi trades at a ~36% NAV discount, but we believe there is no clear catalyst for closure. Q2 faces margin pressure from higher energy costs in VHI's chemicals segment, which we expect will be at least partially offset by rising TiO2 prices. End-market demand, especially in property and homebuilding, remains a concern and will likely reflect in ongoing economics, limiting upside for VHI's core products.
Discover why Zacks, being the first on Wall Street to initiate coverage of the stock, rates Valhi as "Underperform." Explore how VHI's pricing pressure, weak demand and rising costs could weigh on earnings and limit upside potential.
TORONTO, June 16, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today that Novari Health, a VitalHub company, has executed agreements to implement wait list and referral management software technologies at Sunnybrook Health Sciences Centre and across the northern region of British Columbia. Sunnybrook joins hospitals, regional health authorities, and health systems in Canada, Australia and the United Kingdom that have implemented Novari solutions to improve access to care. The Novari solutions are being leveraged in British Columbia to help modernize the region's delivery of surgical, diagnostic imaging, and laboratory services.
Dallas, Texas, May 21, 2026 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE: VHI) announced today that its board of directors has declared a regular quarterly dividend of eight cents ($0.08) per share on its common stock, payable on June 25, 2026 to stockholders of record at the close of business on June 4, 2026.
Vitalhub Corp. (VHI:CA) Q1 2026 Earnings Call Transcript
Dallas, Texas, May 07, 2026 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE: VHI) reported net income attributable to Valhi stockholders of $2.0 million, or $.07 per share, in the first quarter of 2026 compared to net income of $16.9 million, or $.59 per share, in the first quarter of 2025. Net income attributable to Valhi stockholders decreased in the first quarter of 2026 compared to the first quarter of 2025 primarily due to lower operating results from the Chemicals Segment, partially offset by higher operating income from the Component Products and the Real Estate Management and Development Segments.
TORONTO, April 29, 2026 (GLOBE NEWSWIRE) -- VitalHub Corp. (TSX:VHI) (OTCQX:VHIBF) (the "Company" or "VitalHub") announced today that it will release financial results for the first quarter 2026 ended March 31, 2026, after market close on May 7, 2026. The Company will subsequently hold a conference call on May 8, 2026, at 9:00am EST, hosted by CEO Dan Matlow and CFO Brian Goffenberg with a Q&A session to follow.
Dallas, Texas, April 14, 2026 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE: VHI) announced today that, subject to the completion of quarter-end closing procedures, it expects to report first quarter 2026 earnings in a press release after market close on Thursday, May 7, 2026.
